Nenad lisuride transdermal patch regulatory update

Axxonis withdrew an MAA for Nenad lisuride transdermal patch to treat moderate to severe idiopathic restless legs syndrome (RLS). In November, EMEA's CHMP issued a negative opinion on the application ...